We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0RKM market cap is 89.93M. The company's latest EPS is PLN 0.0677 and P/E is 18.91.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Revenue | 39.11M | 40.16M | 41.15M | 50.38M | 58.61M |
| Operating Income | 5.99M | 6.82M | 7.14M | 10.28M | 8.87M |
| Net Income | 2.48M | 4.44M | 4.25M | 6.08M | 4.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Assets | 81.11M | 85.86M | 116.83M | 163.1M | 265.9M |
| Total Liabilities | 48.24M | 48.56M | 42.27M | 57.54M | 153.26M |
| Total Equity | 32.87M | 37.31M | 74.55M | 105.56M | 112.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Operating | 8.16M | 343k | -3.28M | 2.95M | -5.35M |
| Investing | -690k | -2.03M | -4.49M | -26.97M | -72.9M |
| Financing | -6.87M | 2.86M | 20.22M | 36.82M | 53.33M |
| Market Cap | 89.93M |
| Price to Earnings Ratio | 18.91 |
| Price to Sales Ratio | 1.53 |
| Price to Cash Ratio | 41.29 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 70.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Synthaverse Sa |
| Address |
uniwersytecka 10, 20-029 lublin |
| Website | https://synthaverse.com/pl |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
